As one of the most important representatives of serine proteases, subtilisin-like serine proteases are widely present in a diversity of organisms, but mainly in plants. Subtilases have a wide range of biological functions, from protein turnover and plant development to interactions with the environment, and they have been gaining increasing attention with regard to their involvement in plant defence responses against the most diverse pathogens. As a result, there has been an increasing number of studies on subtilases and serine protease inhibitors secreted by pathogens. These extracellular proteases secreted by fungi may act as virulence factors. Such secreted enzymes may play a central role in the establishment of pathogens. Although subtilisin-like serine proteases are expanded among pathogenic fungi, this group of proteases is also ubiquitous among eukaryotes and presents a new and interesting target for drug development.
BOC Sciences is focused on offering 1,000 drug-like screening compounds that are small-molecule analogs of known subtilisin-like serine proteinase inhibitors with experimentally determined activity.
Figure 1. Crystal structure of a subtilisin-like serine proteinase from a psychrotrophic Vibrio species. (Jóhanna, A.; et al. 2005)
BOC Sciences has designed a receptor-based library of potential subtilisin-like serine protease inhibitors by employing docking approach and molecular fitting method.
BOC Sciences provides professional, rapid and high-quality services of Subtilisin-like Serine Protease Targeted Library design at competitive prices for global customers. Personalized and customized services of Subtilisin-like Serine Protease Targeted Library design can satisfy any innovative scientific study demands. Our clients have direct access to our staff and prompt feedback to their inquiries. If you are interested in our services, please contact us immediately!
Reference
BOC Sciences has rich experience in working with global customers in custom library synthesis of compounds and generating small to medium-sized libraries of target compounds. Our knowledge in generating a large number of target molecules in a remarkably shorter time enables quick biological screenings for affinities. With the target properties in mind, we deliver target molecules, by applying our extensive knowledge in drug discovery.